Original Article

Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals
  • Sibel YILDIZ KAYA
  • Bilgül METE
  • Abdurrahman KAYA
  • Ilker Inanç BALKAN
  • Nese SALTOGLU
  • Fehmi TABAK
Viral Hepat J 2017; 23: 6-9 DOI: 10.4274/vhd.52724

Research Article

Long-term Sustained Virological Response Rate in Treatment of Chronic Hepatitis C Patients
  • Mustafa SÜNBÜL
  • Tuba KURUOĞLU
  • İsmail Hakkı DÜNDAR
  • Şaban ESEN
  • Cafer EROĞLU
  • Hakan LEBLEBİCİOĞLU
Viral Hepat J 2008; 13: 7-11
The Role of the Basal Core Promoter (BCP) and Precore Codon 28 Mutations in the Treatment Response to the Pegylated Interferon
  • Şükran KÖSE
  • Süheyla Serin SENGER
  • Gülsün ÇAVDAR
  • Pelin ADAR
Viral Hepat J 2014; 20: 19-22 DOI: 10.4274/Vhd.74946
Does Vitamin D Level Affect the Response to Antiviral Treatment in Egyptian Patients with Chronic Hepatitis C?
  • Hoda Abdelbadie HUSSEIN
  • Hany Badreldin MOHAMAD
  • Mohamad Abdelhadi MASHAHEET
  • Maher Abubakr ALAMIR
  • Ghada Mohamad EZZAT
Viral Hepat J 2017; 23: 50-54 DOI: 10.4274/vhd.73745
The Evaluation of the Seroprevalence of HBV and HCV Infections in Patients with Hemodialysisin Hatay City and the Assessment of Antibody Response to Hepatitis B Vaccination
  • Ömer EVİRGEN
  • Yusuf ÖNLEN
  • Vicdan KÖKSALDI MOTOR
  • Erkan MAHSERECİ
  • Melek İNCİ
  • Şule ŞAHİN
Viral Hepat J 2010; 16: 57-63
Antibody Response to Hepatitis B Vaccination in Isolated Anti-Hbc IgG Positive Cases
  • Esra Kazak
  • Emel YILMAZ
  • Reşit MISTIK
  • Halis AKALIN
  • Semra AKGÖZ
  • Güher Göral
Viral Hepat J 2012; 18: 71-75 DOI: 10.4274/Vhd.76486
Evaluation of 219 Patients with Chronic Hepatitis C Receiving Pegylated Interferon + Ribavirin Treatment
  • Nevil AYKIN
  • Figen ÇAĞLAN ÇEVİK
  • Hasan NAZ
  • Pınar KORKMAZ
  • Tercan US
Viral Hepat J 2013; 19: 71-75 DOI: 10.4274/Vhd.77486
Hepatitis C Prevalence and Responses to Pegylated Interferon + Ribavirin Treatment Among Prisoners
  • Hasan Selçuk ÖZGER
  • Ömer KARAŞAHİN
  • Mehmet Armağan TOY
  • Sibel İBA YILMAZ
  • Kenan HIZEL
Viral Hepat J 2017; 23: 71-75 DOI: 10.4274/vhd.0007
Investigation of Antibody Responses in a Model of Hepatitis B Virus (HBV) Surface Antigen (HBsAg) and Specific Antibody Complex
  • Resul KARAKUS
  • Cemalettin AYBAY
Viral Hepat J 2007; 12: 73-81
Evaluation of Sustained Virological Response in Patients with Genotype 1b Chronic Hepatitis C Infection
  • Esragül AKINCI
  • Bircan ÜNAL KAYAASLAN
  • Aliye TANRICI BAŞBUĞ
  • Selim Sırrı EREN
  • Pınar ÖNGÜRÜ
  • Hürrem BODUR
Viral Hepat J 2013; 19: 80-84 DOI: 10.4274/Vhd.68077
Comparison of the Efficacy of Standard Interferon Alpha 2a Plus Ribavirin and PegylatedInterferon Alpha 2a Plus Ribavirin Combination Therapies in the Treatment of ChronicHepatitis C Infection
  • Şua SÜMER
  • Onur URAL
  • Nazlım AKTUĞDEMİR
  • Gaye URAL
  • Mehmet BALCI
  • Nebahat DİKİCİ
Viral Hepat J 2009; 14: 89-90
Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t)ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience
  • Pınar KORKMAZ
  • Figen ÇEVİK ÇAĞLAN
  • Nevil AYKIN
  • Hasan NAZ
  • Onur TOKA
Viral Hepat J 2016; 22: 92-96 DOI: 10.4274/vhd.94830
Evaluation of Long-Term Follow-Up Results of the Patients with Anti-HDV Positivity
  • Bahadir CEYLAN
  • Muzaffer FINCANCI
  • Cüneyt MÜDERRISOGLU
  • Ferda SOYSAL
  • Gülhan EREN
Viral Hepat J 2007; 12: 95-102
Interleukin 28B rs12979860 CT, rs12980275 GA, rs8099917 GT and TT genotypes are the Predictors of Rapid Viral Response in Hepatitis C Virus-Infected Patients
  • Aydin RÜSTEMOĞLU
  • Didem YALÇIN
  • Özgür GÜNAL
  • Betül ÇELİK
  • Şener BARUT
  • Ömer ATEŞ
Viral Hepat J 2016; 22: 97-102 DOI: 10.4274/vhd.51523
Is a Booster Dose of Primary Vaccinationagainst Hepatitis B Necessary After Five Years?
  • Selma TOSUN
  • Selahattin AKSU
Viral Hepat J 2009; 14: 98-103
The Factors Mfecting the Sustained Virological Response in Chronic Hepatitis C Treatment
  • Yunus GÜRBÜZ
  • Ediz TÜTÜNCÜ
  • Barış ÖZTÜRK
  • Ferit KUŞÇU
  • İrfan ŞENCAN
Viral Hepat J 2008; 13: 106-110
The Evaluation of the Seroprevalence of HBV, HCV and HIV Infections and the Assessment of Antibody Response to Hepatitis B Vaccination in Hemodialysis Patients
  • Hakan TEMİZ
  • Şafak KAYA
  • Nuh BEREKATOĞLU
  • Sevim TEMİZ
  • Ramazan DANIŞ
Viral Hepat J 2013; 19: 140-143 DOI: 10.4274/Vhd.66375

Research Article

An Evaluation of Chronic Hepatitis C Patients’ Responses to Direct-Acting Antivirals According to Transient Elastography and Serum Biomarkers
  • Nurten Nur Aydın
  • İftihar Köksal
Viral Hepat J 2022; 28: 18-24 DOI: 10.4274/vhd.galenos.2022.2021-8-2
The Long-term (10.6 years) Outcome of Hepatitis C patients with Sustained Virologic Response Following Treatment with Pegylated Interferon + Ribavirin
  • Osman Özdoğan
  • Serkan Yaraş
Viral Hepat J 2020; 26: 22-27 DOI: 10.4274/vhd.galenos.2019.2019.0042
Effect of Advanced Fibrosis Presence on Adherence to Hepatocellular Carcinoma Surveillance in Chronic Hepatitis C Patients with Sustained Virologic Response
  • Göktuğ Şirin
  • Sadettin Hülagü
Viral Hepat J 2020; 26: 32-38 DOI: 10.4274/vhd.galenos.2020.2020.0002
Long-term Kinetics of Alpha-fetoprotein in Chronic Hepatitis C Patients Treated with Direct-acting Antivirals and Possible Predictive Role of AFP Response to Treatment on Development of Hepatocellular Carcinoma
  • Celal Ulaşoğlu
  • Banu Erkalma Şenateş
  • Suna Yapalı
  • Betül Dumanoğlu
  • Feruze Enc
  • Yaşar Çolak
  • Ebubekir Şenateş
Viral Hepat J 2021; 27: 49-52 DOI: 10.4274/vhd.galenos.2021.2021-5-3
Evaluation of Direct-acting Antiviral Agents and Clinical Responses in Chronic Hepatitis C Patients
  • Esra Zerdalı
  • İnci Yılmaz Nakir
  • Filiz Pehlivanoğlu
Viral Hepat J 2022; 28: 79-84 DOI: 10.4274/vhd.galenos.2022.2022-4-2
Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data
  • Ayla Doğrugörün
  • Elif Doyuk Kartal
  • Saygın Nayman Alpat
Viral Hepat J 2023; 29: 95-100 DOI: 10.4274/vhd.galenos.2023.2023-6-1
Treatment Response to Oral Antivirals in Chronic Hepatitis B Patients: Assessment of Polymorphism in the IL-28B Gene (rs809991)
  • Tuba İlgar
  • Çiğdem Ataman Hatipoğlu
  • Cemal Bulut
  • Şerife Altun Demircan
  • Sami Kınıklı
Viral Hepat J 2023; 29: 108-113 DOI: 10.4274/vhd.galenos.2023.2023-9-3
Influence of Sustained Virological Response on APRI in Chronic Hepatitis C: is APRI a Marker of Only the Stage of Fibrosis?
  • Özgür Bahadır
  • Serhat Özer
  • Ayça Gökçen Değirmenci Saltürk
  • Halil Şahin
  • Mevlüt Kıyak
  • Emine Kanatsız
  • Cüneyt Saltürk
  • Fatih Güzelbulut
Viral Hepat J 2020; 26: 119-123 DOI: 10.4274/vhd.galenos.2020.2020.0012
Effect of Hepatitis B Virus Genotypes and Viral Load on the Response of Patients Treated with Peginterferon-α-2a
  • Majid Mahmood
  • Muhammad Asim Anwar
  • Muhammad Naseem Hasrat
  • Zahid Azam
Viral Hepat J 2021; 27: 131-135 DOI: 10.4274/vhd.galenos.2021.2021-5-6
Investigating the Prevalence of Hepatitis Delta and Assessment of Treatment Response
  • Pınar Ergen
  • Fatma Yılmaz Karadağ
  • Özlem Aydın
Viral Hepat J 2020; 26: 135-140 DOI: 10.4274/vhd.galenos.2020.2020.0025

Other

COMPARISON OF SEROCONVERTATION RATES OF DIFFERENT HBV VACCINES
  • Yunus GÜRBÜZ
  • Ediz TÜTÜNCÜ
  • Güven ÇELEBI
  • Rüçhan TÜRKYILMAZ
Viral Hepat J 2000; 6: 0-0
ADANA BAYINDIRLIK VE ISKAN MÜDÜRLÜGÜ ÇALISANLARININ VE AILELERININ HEPATIT B TASIYICILIGI VE TAKIBI ILE HEPATIT B ASILARINA KARSI IMMÜN CEVABIN PROSPEKTIF OLARAK DEGERLENDIRILMESI.
  • Atiye FEDAKAR
  • Ali FEDAKAR
Viral Hepat J 2000; 6: 0-0
The Evaluation of Immune Responses That Occur After HBV Infection and HBV Vaccination in Hemodialysis Patients
  • Ismail Hamdi KARA
  • Ali SÜNER
  • Ali Kemal KADIROGLU
  • M.Emin YILMAZ
  • Bünyamin ISIKOGLU
Viral Hepat J 2003; 8: 0-0
Long-Term Follow-Up of Hepatitis C Patients with Virological and Biochemical Response to Therapy and Investigation of Factors Predicting Relapses
  • Bahadir CEYLAN
  • Muzaffer FINCANCI
  • Cüneyt MUDERRISOGLU
  • Ferda SOYSAL
  • Gülhan EREN
Viral Hepat J 2007; 12: 14-23
Isolated Anti-HBc Positive B Virüs Serology and Response to HBV Vaccine
  • Tijen ÖZACAR
  • Aysin ZEYTINOGLU
  • Selda ERENSOY
  • Nur YAPAR
  • Mine HOSGÖR
  • Altinay BILGIÇ
Viral Hepat J 1995; 1: 69-71
Evaluation of the Response to Hepatitis B Virus Vaccine in Ambulatory Peritoneal Dialysis Patients
  • Tansu YAMAZHAN
  • Bilgin ARDA
  • Gülay ASÇI
  • Ercan OK
  • Sercan ULUSOY
Viral Hepat J 2003; 8: 139-142
ISOLATED ANTI-HBC POSITIVE SUBJECTS AND THEIR RESPONSE TO HEPATITIS B VACCINE
  • Özlem KANDEMIR
  • Cemil BAYARSLAN
  • Ali KAYA
Viral Hepat J 2002; 8: 430-431
EVALUATION OF EXPOSURES TO BLOOD AND BODY FLUIDS IN ANKARA NUMUNE EDUCATION AND RESEARCH HOSPITAL WORKERS
  • Ayse ERBAY
  • Önder ERGÖNÜL
  • Hürrem BODUR
  • Münire KORKMAZ
  • Nefise ÖZTOPRAK
  • Esragül AKINCI
Viral Hepat J 2002; 8: 497-501